U.S. Markets closed

Endocyte, Inc. (ECYT)

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
1.38-0.03 (-2.13%)
At close: 4:00PM EDT

1.41 +0.03 (2.17%)
After hours: 4:34PM EDT

People also watch
Full screen
Previous Close1.41
Bid1.38 x 700
Ask2.00 x 400
Day's Range1.38 - 1.43
52 Week Range1.17 - 3.49
Avg. Volume475,279
Market Cap58.75M
PE Ratio (TTM)-1.36
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cube21 days ago

    ETFs with exposure to Endocyte, Inc. : August 31, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Endocyte, Inc. Here are 5 ETFs with the largest exposure to ECYT-US. Comparing the performance and risk of Endocyte, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Endocyte, Inc. :ECYT-US: Earnings Analysis: Q2, 2017 By the Numbers : August 24, 2017
    Capital Cube29 days ago

    Endocyte, Inc. :ECYT-US: Earnings Analysis: Q2, 2017 By the Numbers : August 24, 2017

    Categories: Yahoo FinanceGet free summary analysis Endocyte, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Endocyte, Inc. – Amgen Inc., Madrigal Pharmaceuticals, Inc., Johnson & Johnson, Merck & Co., Inc., Nektar Therapeutics, General Electric Company, AbbVie, Inc. and Verastem, Inc. (AMGN-US, MDGL-US, JNJ-US, MRK-US, ... Read more (Read more...)

  • Thomson Reuters StreetEventslast month

    Edited Transcript of ECYT earnings conference call or presentation 8-Aug-17 8:30pm GMT

    Q2 2017 Endocyte Inc Earnings Call